CCAS can also be seen in complex cerebrocerebellar pathological conditions, such as cerebellar and brainstem hemorrhage, complex cerebrocerebellar degeneration with gene variants (senataxin, gene, and X-linked recessive ATP2B3 gene), pontine cavernous malformation, ataxia with oculomotor apraxia type 2 (AOA2), Friedreichs ataxia, SCA1, SCA2, SCA3, SCA7, SCA17, and multiple system atrophy of the cerebellar type (MSA-C) [9]
The released fatty acids can then be used by the body for energy metabolism
Misuse of these materials is strictly prohibited
Pei, J., Pan, X., Wei, G., & Hua, Y
Compliance Note Atlas BioLabs supplies this product for qualified B2B sourcing, research, formulation, and documentation review contexts only